1.Neovascular glaucoma: challenges we have to face.
Chinese Medical Journal 2014;127(8):1407-1409
2.Photodynamic Therapy for Subretinal New Vessels.
Sung Chul LEE ; Jeong Hun BAE ; Hyung Jun KOH ; Sung Soo KIM ; Oh Woong KWON
Yonsei Medical Journal 2007;48(2):325-327
Photodynamic therapy (PDT) involves the induction of endothelial cell death or occlusion of blood vessels. On the basis of this mechanism of action, PDT is used in the treatment of predominant classic choroidal neovascularization (CNV), if the classic component is over 50%, and in myopic CNV. This study describes 2 cases of distinctive, abnormal, large, subretinal new vessels that are thought to have originated from the choroids. Diminishment of the new vessels was observed following treatment with PDT.
Retinal Vessels/drug effects/*pathology
;
Retinal Diseases/*drug therapy/pathology
;
*Photochemotherapy
;
Neovascularization, Pathologic/*drug therapy/pathology
;
Middle Aged
;
Male
;
Humans
;
Female
;
Angiography
3.Early surgical management in bilateral acute retinal necrosis.
Korean Journal of Ophthalmology 1990;4(1):46-49
One patient with bilateral acute retinal necrosis underwent encircling scleral buckle, vitrectomy, and intravitreal acyclovir on both eyes. This procedure was performed on the right eye while the retina was attached. The retina of the right eye was reattached by performing fluid-gas exchange and modified panretinal photocoagulation when the retina subsequently detached. Soon after the development of retinal detachment in the left eye, the above surgical procedures were performed on the left eye, and the retina was successfully reattached.Bilateral acute retinal necrosis with significant vitreous opacification, which is a devastating ocular disease causing possible blindness in both eyes, requires more aggressive, early surgical management.
Acute Disease
;
Acyclovir/therapeutic use
;
Adult
;
Fundus Oculi
;
Humans
;
Light Coagulation
;
Male
;
Necrosis/surgery
;
Retinal Detachment/surgery
;
Retinal Diseases/drug therapy/pathology/*surgery
;
Scleral Buckling
;
Syndrome
;
Vitrectomy
4.An Atypical Case of Aicardi Syndrome with Favorable Outcome.
Seung Woo LEE ; Kwang Soo KIM ; Sung Min CHO ; Sun Joo LEE
Korean Journal of Ophthalmology 2004;18(1):79-83
Aicardi syndrome is a severe congenital disorder characterized by infantile spasms, chorioretinal lacunae, and agenesis or hypogenesis of the corpus callosum. A 6 month old female had developed abnormal eye movement and seizures of the complex partial type and myoclonic type. MRI pictures of the patient revealed the presence of genu associated with agenesis of the rest of corpus callosum. A funduscopic examination revealed bilateral small, solitary, pale areas with sharp borders, some of which had minimal surrounding pigmentation (chorioretinal lacunae), especially clustered around the disc, and they were more prominent on the left side. We report here on the unusual findings of a complex partial seizure, myoclonic seizure and the atypical EEG finding in addition to the well-known characteristic clinical and imaging findings of a patient with Aicardi syndrome.
Anticonvulsants/therapeutic use
;
Arachnoid Cysts/*pathology
;
Corpus Callosum/*abnormalities
;
Electroencephalography
;
Epilepsies, Myoclonic/drug therapy/*pathology
;
Epilepsies, Partial/drug therapy/*pathology
;
Female
;
Humans
;
Infant
;
Magnetic Resonance Imaging
;
Retinal Diseases/*pathology
;
Spasms, Infantile/drug therapy/*pathology
;
Syndrome
5.Acetazolamide for Cystoid Macular Oedema in Bietti Crystalline Retinal Dystrophy.
Geoffrey K BROADHEAD ; Andrew A CHANG
Korean Journal of Ophthalmology 2014;28(2):189-191
Bietti crystalline retinal dystrophy is a rare, inherited disorder whose hallmark is the presence of retinal crystal deposits associated with later chorioretinal degeneration. This condition may rarely be complicated by the development of cystoid macular oedema leading to rapid visual decline. Currently, treatment options for this complication of Bietti dystrophy are limited and the visual prognosis is poor. Here, we present a case of cystoid macular oedema associated with Bietti dystrophy that was successfully diagnosed using multimodal imaging techniques including optical coherence tomography and fluorescein angiography. These modalities confirmed the diagnosis of macular oedema and excluded other possible causes of oedema such as choroidal neovascularisation. In this patient, cystoid macular oedema was resolved with oral acetazolamide therapy, a treatment that has not been previously reported in this context. Acetazolamide treatment resulted in oedema resolution and improvement in visual function, and can be considered a therapeutic option for other patients with Bietti dystrophy who develop cystoid macular oedema.
Acetazolamide/*administration & dosage
;
Administration, Oral
;
Adult
;
Corneal Dystrophies, Hereditary/*drug therapy/pathology
;
Diuretics/*administration & dosage
;
Humans
;
Macular Edema/*drug therapy/pathology
;
Male
;
Retinal Diseases/*drug therapy/pathology
;
Tomography, Optical Coherence
;
Treatment Outcome
6.Recurrent Bilateral Branch Retinal Artery Occlusion with Hearing Loss and Encephalopathy: The First Case Report of Susac Syndrome in Korea.
Soo Geun JOE ; June Gone KIM ; Sun Uck KWON ; Choong Wook LEE ; Hyun Woo LIM ; Young Hee YOON
Journal of Korean Medical Science 2011;26(11):1518-1521
We report the first case of Susac syndrome in Koreans, in a 23-yr-old female patient who presented with sudden visual loss and associated neurological symptoms. Ophthalmic examination and fluorescein angiography showed multiple areas of branch retinal artery occlusion, which tended to recur in both eyes. Magnetic resonance imaging showed dot-like, diffusion-restricted lesions in the corpus callosum and left fornix, and audiometry showed low-frequency sensory hearing loss, compatible with Susac syndrome. She received immunosuppressive therapy with oral steroid and azathioprine. Three months later all the symptoms disappeared but obstructive vasculitis have been relapsing. This patient demonstrated the entire clinical triad of Susac syndrome, which tends to occur in young females. Although this disorder has rarely been reported in Asian populations, a high index of suspicion is warranted for early diagnosis and timely treatment.
Autoimmune Diseases/diagnosis/drug therapy
;
Azathioprine/administration & dosage/*therapeutic use
;
Brain/blood supply/pathology
;
Female
;
Hearing Loss
;
Humans
;
Immunotherapy
;
Magnetic Resonance Imaging
;
Republic of Korea
;
Retinal Artery Occlusion/diagnosis/drug therapy/pathology
;
Susac Syndrome/*diagnosis/*drug therapy/pathology
;
Young Adult
7.Resolution of Severe Macular Edema in Adult Coats' Disease with Intravitreal Triamcinolone and Bevacizumab Injection.
Jong Hwa JUN ; Yu Cheol KIM ; Kwang Soo KIM
Korean Journal of Ophthalmology 2008;22(3):190-193
A 47 year old male patient visited our hospital with the chief complaint of deterioration of the visual acuity in the left eye. The fundus examination revealed thick hard exudates, multiple aneurysms and telangiectasias of the retinal vessels in the posterior pole. Fluorescein angiography demonstrated massive leakage over an area of the aneurysms. Optical coherence tomography (Stratus OCT; Zeiss-Humphrey, Dubin, CA) revealed diffuse and marked thickening of the retina. Laser photocoagulation was performed under the diagnosis of Coats' disease. However, the treatment could not be performed satisfactorily. On the first and 6th weeks, an intravitreal injection of bevacizumab and triamcinolone acetonide was administered, and laser photocoagulation was again attempted. The effectiveness of eachagent on retinal edema was evaluated at the follow-up performed at 1, 2, 5, 7, 10 weeks and 6 months after the injection. At one week after the intravitreal bevacizumab injection, there was no improvement. An intravitreal injection of triamcinolone acetonide was performed 6 weeks after the initial diagnosis,which resulted in a reduction in the thickness of the macular edema. Therefore, laser photocoagulation was performed sufficiently on telangiectasias. The follow-up at 6 months showed a relative increase in the macular edema, but there was reduced leakage from the telangiectasias compared with the previous angiograph.
Angiogenesis Inhibitors/*therapeutic use
;
Antibodies, Monoclonal/*therapeutic use
;
Drug Therapy, Combination
;
Fluorescein Angiography
;
Glucocorticoids/*therapeutic use
;
Humans
;
Injections
;
Laser Coagulation
;
Macular Edema/*drug therapy/etiology
;
Male
;
Middle Aged
;
Retinal Diseases/complications/*drug therapy/surgery
;
Retinal Vessels/pathology
;
Telangiectasis/complications/*drug therapy/surgery
;
Tomography, Optical Coherence
;
Triamcinolone Acetonide/*therapeutic use
;
Vascular Endothelial Growth Factor A/antagonists & inhibitors
;
Vitreous Body
8.Optic Disc Pit with Peripapillary Retinoschisis Presenting as a Localized Retinal Nerve Fiber Layer Defect.
In Seok SONG ; Joong Won SHIN ; Yong Woon SHIN ; Ki Bang UHM
Korean Journal of Ophthalmology 2011;25(6):455-458
A 59-year-old woman was referred to our clinic for a glaucoma evaluation. The visual acuity and intraocular pressure were normal in both eyes. However, red-free fundus photography in the left eye showed a superotemporal wedge-shaped retinal nerve fiber layer defect, and visual field testing showed a corresponding partial arcuate scotoma. In an optical coherence tomography examination, the macula was flat, but an arcuate-shaped peripapillary retinoschisis was found. Further, the retinoschisis seemed to be connected with a superotemporal optic pit shown in a disc photograph. After 3 months of a topical prostaglandin analogue medication, the intraocular pressure in the retinoschisis eye was lowered from 14 to 10 mmHg and the peripapillary retinoschisis was almost resolved. We report a rare case of an optic disc pit with peripapillary retinoschisis presenting as a localized retinal nerve fiber layer defect.
Female
;
Humans
;
Middle Aged
;
Nerve Fibers/*pathology
;
Optic Disk/*abnormalities/*pathology
;
Optic Nerve Diseases/*diagnosis
;
Retinal Ganglion Cells/*pathology
;
Retinoschisis/*diagnosis/drug therapy
;
Tomography, Optical Coherence
9.Therapeutic effect of bFGF on retina ischemia-reperfusion injury.
Ying-jun NIU ; Yan-song ZHAO ; Yun-xia GAO ; Zhan-yu ZHOU ; Hong-yun WANG ; Chun-yan YUAN
Chinese Medical Journal 2004;117(2):252-257
BACKGROUNDBasic fibroblast growth factor (bFGF) plays important roles in retina degeneration, light injury, mechanical injury, especially in retina ischemia-reperfusion injury (RIRI). This study was to investigate the therapeutical effect of bFGF on RIRI and its mechanisms.
METHODSExperimental RIRI was induced by increasing intraocular pressure (IOP) in the eyes of 48 rats. These rats were divided into normal control, ischemia-reperfusion and bFGF-treated groups. Histological and ultrastructural changes of in the retina of different groups were observed, and the number of retinal ganglion cells (RGCs) was quantitatively analyzed under microscopy. Apoptotic cells were detected using the TdT-dUTP terminal nick-end labeling (TUNEL) method. The expression of caspase-3 was determined by streptavidin peroxidase (SP) immunohistochemistry. Atomic absorption spectrum method was used to evaluate the intracellular calcium changes.
RESULTSAt the early stage of retinal ischemia-reperfusion injury, retina edema in the treated group was significantly eliminated compared with the untreated ischemic animals. RGCs in the bFGF-treated group was more than those in the untreated ischemic group during the post-reperfusion stages. In ischemic group, apoptotic cells could be found at 6th hour after reperfusion and reached the peak at 24 hours. At 72nd hour no apoptotic cells could be found.The changes in caspase-3 expression had a similar manner. The intracellular calcium of rat retina began to increase at 1st hour, reached the peak at 24 hours, and began to decrease at 72 hours. The change of the three markers in the treatment group showed a similar pattern, but they were all relatively less obvious.
CONCLUSIONApoptosis may play a vital role in RIRI. bFGF may has therapeutical effects on RIRI by inhibiting the increase of intracellular calcium and caspase-3 expression.
Animals ; Apoptosis ; Calcium ; analysis ; Caspase 3 ; Caspases ; analysis ; Fibroblast Growth Factor 2 ; therapeutic use ; Rats ; Rats, Wistar ; Reperfusion Injury ; drug therapy ; metabolism ; pathology ; Retinal Diseases ; drug therapy ; metabolism ; pathology
10.Clinical Features of Idiopathic Juxtafoveal Telangiectasis in Koreans.
Seung Woo LEE ; Sung Min KIM ; Yun Taek KIM ; Se Woong KANG
Korean Journal of Ophthalmology 2011;25(4):225-230
PURPOSE: To describe the clinical characteristics of idiopathic juxtafoveal telangiectasis (IJT) in Koreans. METHODS: Medical records of 16 patients with IJT were analyzed during the period from 1997 to 2009. Diagnosis was based on biomicrosopic and fluorescein angiographic findings and the group was determined according to the Gass and Blodi classification. RESULTS: We analyzed eight patients in group 1A (50%), two in group 1B (12.5%), and six in group 2A (37.5%). Diverse treatment modalities, such as macular laser photocoagulation, photodynamic therapy, intravitreal antiangiogenic agent, and steroid injection, were applied for macular edema in nine eyes; however, only two eyes showed visual improvement. CONCLUSIONS: In this case series, group 1A was the most common. For macular edema related to IJT, current treatment strategies had no consistent effect.
Adolescent
;
Adult
;
Aged
;
Angiogenesis Inhibitors/administration & dosage
;
Child
;
Female
;
Fluorescein Angiography
;
Follow-Up Studies
;
Fovea Centralis/*blood supply
;
Fundus Oculi
;
Glucocorticoids/administration & dosage
;
Humans
;
Incidence
;
Intravitreal Injections
;
Male
;
Microscopy, Acoustic
;
Middle Aged
;
Photochemotherapy/methods
;
Prognosis
;
Republic of Korea/epidemiology
;
Retinal Diseases/*diagnosis/drug therapy/epidemiology
;
Retinal Vessels/*pathology/ultrasonography
;
Retrospective Studies
;
Risk Factors
;
Telangiectasis/*diagnosis/drug therapy/epidemiology
;
Visual Acuity
;
Young Adult